朗玛信息(300288) - 2025 Q4 - 年度业绩预告

Financial Performance - The company expects a net profit of between 1,000 and 1,450 million yuan for 2025, indicating a turnaround from a loss of 51,209.97 million yuan in the previous year[3] - The net profit after deducting non-recurring gains and losses is projected to be between 650 and 950 million yuan, compared to a loss of 51,837.21 million yuan last year[3] - The impact of non-recurring gains and losses on the current net profit is estimated to be around 4.29 million yuan, down from 6.27 million yuan in the previous year[6] Business Strategy - The company is actively adjusting its development strategy, focusing on medical artificial intelligence technology research and product development, with the "39AI Doctor" platform now offering various functionalities[6] - The company aims to promote its products primarily to the B2B market, targeting medical institutions[6] - Cost control measures and optimization of business structure are being implemented to enhance profitability[6] Goodwill Impairment - The company plans to recognize an additional goodwill impairment of approximately 3.6 million yuan due to ongoing declines in the business income of its subsidiary, Qisheng Information[6] Reporting Schedule - The company has scheduled the disclosure of its 2025 annual report for April 28, 2026, where detailed business data will be provided[7]